Peripheral Interventions Market Size & Growth Forecast 2027–2036, By Segments (Application, Proudct, End-use), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape

Market Size and Growth Outlook

Peripheral Interventions Market size stood at USD 11.72 Billion in 2026 and is predicted to grow at 9.65% CAGR from 2027 to 2036, reaching USD 29.45 Billion by 2036. The industry revenue for 2027 is assessed at USD 12.68 Billion.

• Base Year Value (2026): USD 11.72 Billion
• CAGR (2027-2036): 9.65%
• Forecast Year Value (2036): USD 29.45 Billion
• Historical Data Period: 2022-2026
• Largest Region: North America
• Forecast Period: 2027-2036

Peripheral Interventions Market Intelligence Snapshot:

• Regional Market Dynamics:

  • North America leads through advanced healthcare infrastructure, high minimally invasive procedure adoption, specialized vascular care, device innovation, and established reimbursement mechanisms.
  • Asia Pacific is growing fastest as healthcare infrastructure improves, vascular disease prevalence rises, and hospitals expand access to specialized cardiovascular and minimally invasive care.

• Segment Momentum:

  • Peripheral artery disease led the market in 2025 due to its high clinical burden, increasing preference for minimally invasive procedures, improved endovascular techniques, and broader access to specialized vascular care.
  • Ambulatory surgical centers are expanding rapidly as more minimally invasive vascular procedures move to outpatient settings, offering shorter treatment times, operational efficiency, and cost-effective patient care.

• Market Expansion Drivers:

  • Increasing cardiovascular disease burden driving demand for minimally invasive peripheral interventions
  • Expanding adoption of catheter-based minimally invasive procedures improving procedural efficiency and outcomes
  • Growth of catheterization laboratories in emerging markets expanding access to vascular intervention procedures

• Leading Market Participants:

  Leading players in the peripheral interventions market include Boston Scientific Corporation (United States), Medtronic plc (Ireland), Abbott Laboratories (United States), Terumo Corporation (Japan), Becton, Dickinson and Company (United States), Cook Medical LLC (United States), Teleflex Incorporated (United States), W. L. Gore & Associates, Inc. (United States), AngioDynamics, Inc. (United States), Biotronik SE & Co. KG (Germany)

Unlock Complete Insights

Global Market Forecast Snapshot:

• Market Outlook:

  • 2026 Market Size: USD 11.72 Billion
  • 2027 Estimated Market Size: USD 12.68 Billion
  • Projected Market Size: USD 29.45 Billion by 2036
  • Growth Forecasts: 9.65% CAGR (2027-2036)

• Regional and Segment Outlook:

  • Leading Regional Market: North America
  • High-Growth Regional Hub: Asia Pacific
  • Core Revenue Segment: Peripheral Artery Disease (Application) | Catheters (Proudct) | Hospitals (End-use)
  • Emerging Opportunity Segment: Venous Thromboembolism (Application) | Catheters (Proudct) | Ambulatory Surgical Centers (End-use)

Market Growth Drivers and Industry Trends

Increasing cardiovascular disease burden driving demand for minimally invasive peripheral interventions

The growing prevalence of vascular disorders is increasing the need for effective treatment options that reduce procedural complexity and recovery time, which will drive the peripheral interventions market growth. Rising cardiovascular disease incidence is encouraging healthcare providers to adopt minimally invasive approaches for managing peripheral artery conditions and improving patient outcomes. These procedures offer alternatives to conventional surgical methods by enabling targeted treatment through smaller access points, supporting broader clinical adoption across hospitals and specialized vascular centers.

Expanding adoption of catheter-based minimally invasive procedures improving procedural efficiency and outcomes

Advancements in catheter-based techniques are transforming vascular treatment approaches, supporting expansion of the peripheral interventions market. Physicians are increasingly using minimally invasive devices that provide greater precision, shorter recovery periods, and improved procedural control compared with traditional interventions. Continuous improvements in device design, imaging compatibility, and treatment delivery methods are encouraging wider utilization of catheter-based solutions across complex peripheral vascular procedures.

Growth of catheterization laboratories in emerging markets expanding access to vascular intervention procedures

Healthcare infrastructure development in emerging regions is increasing the availability of specialized cardiovascular care facilities, which will propel the peripheral interventions market demand. The expansion of catheterization laboratories enables hospitals to perform advanced vascular procedures closer to patient populations that previously had limited access to such treatments. Investments in medical infrastructure, clinical capabilities, and specialized equipment are supporting greater adoption of peripheral intervention technologies in developing healthcare systems.

Growth Driver Assessment Framework
Growth Driver	Impact On CAGR	Regulatory Influence	Geographic Relevance	Adoption Rate	Impact Timeline
Increasing cardiovascular disease burden driving demand for minimally invasive peripheral interventions	2%	High	North America, Europe	High	Near Term
Expanding adoption of catheter-based minimally invasive procedures improving procedural efficiency and outcomes	1.8%	High	Asia Pacific	High	Near Term
Growth of catheterization laboratories in emerging markets expanding access to vascular intervention procedures	1.6%	Moderate	Asia Pacific, Latin America	High	Mid Term

Regional Demand Dynamics

North America (Largest Region) vs Asia Pacific (Fastest-Growing Region)

In the peripheral interventions market, North America held the largest position in 2026, supported by advanced healthcare infrastructure, high adoption of minimally invasive procedures, and broad access to specialized vascular care. The growing prevalence of peripheral artery disease and other vascular conditions is increasing the need for diagnostic and therapeutic interventions. Healthcare providers are also increasingly favoring catheter-based approaches because they can reduce procedural invasiveness and support faster recovery. Continued innovation in vascular devices, well-established reimbursement mechanisms, and the availability of specialized interventional facilities are contributing to sustained regional market leadership.

Asia Pacific is projected to register the fastest growth in the peripheral interventions market, driven by improving healthcare infrastructure, expanding access to specialized cardiovascular services, and increasing awareness of vascular diseases. The growing prevalence of diabetes and cardiovascular conditions is creating a larger patient population requiring peripheral vascular interventions. Investments in hospitals and advanced medical facilities are also enabling wider adoption of minimally invasive procedures. As healthcare systems strengthen their interventional capabilities and patients gain greater access to modern treatment options, demand for peripheral intervention technologies is expected to accelerate across the region.

No card data available for this language/report.

Segment Leadership and Growth Trends

 

Application Segment Analysis: Peripheral Artery Disease (Largest Segment) vs Venous Thromboembolism (Fastest-Growing Segment)

Holding the largest share of the peripheral interventions market, the peripheral artery disease segment dominated in 2026. The high clinical burden of arterial blockages and the growing preference for minimally invasive vascular procedures have significantly increased demand for interventional therapies. Greater awareness of early diagnosis, improvements in endovascular treatment techniques, and expanding access to specialized vascular care continue to support the segment’s leading position.

The venous thromboembolism segment is expected to experience the fastest growth as healthcare providers increasingly emphasize timely diagnosis and minimally invasive treatment to reduce complications associated with venous disorders. Rising adoption of catheter-based interventions, greater availability of advanced thrombectomy technologies, and increased clinical focus on improving patient outcomes are driving demand. Continued advancements in vascular intervention techniques further strengthen the growth trajectory of this segment.

Proudct Segment Analysis: Catheters (Largest & Fastest-Growing Segment)

The peripheral interventions market was led by the catheters segment, which held the largest share in 2026 while also representing the fastest-growing product category. Catheters serve as the foundation of a broad range of peripheral vascular procedures by enabling precise access, navigation, and delivery of therapeutic devices during minimally invasive interventions. Continuous innovation in catheter design has enhanced flexibility, maneuverability, and procedural efficiency, encouraging broader clinical adoption. As the volume of endovascular procedures continues to rise and physicians increasingly favor less invasive treatment approaches, demand for advanced catheter technologies is expected to remain strong.

End-use Segment Analysis: Hospitals (Largest Segment) vs Ambulatory Surgical Centers (Fastest-Growing Segment)

Hospitals accounted for the largest share in 2026 owing to their comprehensive vascular care capabilities, advanced imaging infrastructure, and availability of multidisciplinary specialists required for complex peripheral intervention procedures. Their ability to manage emergency cases, perform sophisticated interventions, and provide integrated post-procedural care has reinforced their position as the primary treatment setting.

The ambulatory surgical centers segment is expected to register the fastest growth as more peripheral intervention procedures shift toward outpatient settings supported by technological advancements and minimally invasive techniques. These facilities offer shorter treatment times, operational efficiency, and convenient patient care, making them increasingly attractive for suitable vascular procedures. Growing demand for cost-effective healthcare delivery is further supporting expansion of this segment.

Report Segmentation
Segment	Sub-Segment	Largest Segment	Fastest Growing Segment
Application	Peripheral Artery Disease, Venous Thromboembolism, Others	Peripheral Artery Disease	Venous Thromboembolism
Proudct	Catheters, Sheath, Stents, Guide Wires, Atherectomy Devices, Embolic Devices, Thrombectomy Devices, IVC Filters, Others	Catheters	Catheters
End-use	Hospitals, Catheterization Laboratories, Ambulatory Surgical Centers, Others	Hospitals	Ambulatory Surgical Centers

Competitive Landscape and Market Positioning

Top players in the peripheral interventions market:

1. Boston Scientific Corporation (United States)
2. Medtronic plc (Ireland)
3. Abbott Laboratories (United States)
4. Terumo Corporation (Japan)
5. Becton Dickinson and Company (United States)
6. Cook Medical LLC (United States)
7. Teleflex Incorporated (United States)
8. W. L. Gore & Associates, Inc. (United States)
9. AngioDynamics, Inc. (United States)
10. Biotronik SE & Co. KG (Germany)

Clinical differentiation is increasingly shifting from standalone device performance toward integrated procedural solutions that improve treatment precision, procedural efficiency, and long-term patient management. Competitive positioning is shaped by the ability to expand portfolios across multiple intervention techniques while supporting physicians with advanced imaging compatibility, workflow optimization, and specialized training. At the same time, growing demand for minimally invasive therapies is encouraging sustained investment in next-generation technologies that address increasingly complex vascular conditions, prompting established participants and emerging innovators to compete through continuous product refinement, broader therapeutic coverage, and stronger clinical evidence.

Industry Development/News

Company Name	Date	Key Development
FastWave Medical	Sep-25	The firm appointed principal investigators and formed an official steering committee to direct its upcoming pivotal clinical trials. The operational milestone formalizes the clinical development path for its proprietary intravascular lithotripsy systems designed for complex peripheral vascular interventions.
Shockwave Medical	Apr-25	The enterprise expanded its specialized cardiovascular portfolio by advancing its proprietary intravascular lithotripsy technology systems. The ongoing product line innovation scales the clinical utility of energy-based calcium modification during complex percutaneous peripheral interventional procedures.
FastWave Medical	Jan-25	The company reached critical milestones for its intravascular lithotripsy platform by securing new patent approvals and advancing toward first-in-human clinical studies. The technical progress validates the proprietary design, which targets calcified arterial lesions within high-growth peripheral intervention segments.
Quasar Medical	Sep-24	The medical device manufacturer acquired Ridgeback Technologies to expand its structural product line, directly integrating specialized balloon catheter engineering capabilities. The acquisition strengthens the company's production capacity and clinical footprint within peripheral vascular intervention markets.
Boston Scientific	Jun-24	The company executed a definitive agreement to acquire Silk Road Medical for $1.26 billion, integrating its proprietary transcarotid artery revascularization technology. The strategic transaction expands the acquirer's portfolio of minimally invasive neurovascular and peripheral intervention solutions, addressing critical stroke prevention requirements.
Boston Scientific	Dec-22	The corporation announced a definitive agreement to acquire a majority stake of up to 65% in Chinese medical technology firm Acotec. The transaction strategically broadens the company's global footprint and commercial capabilities within the interventional vascular device segment across emerging markets.